Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2021 Second quarter results announcement
We announced our second quarter results for the period ended 30 June 2021 on Wednesday 28 July.
Latest information
Latest press releases
- GSK receives CHMP positive opinions recommending approval of Nucala (mepolizumab) in three additional eosinophil-driven diseases
- GSK to highlight continued progress in oncology pipeline and portfolio with data presented at ESMO
- GSK Consumer Healthcare leads oral care industry with launch of its first carbon neutral toothbrush
New GSK Investor update
Emma Walmsley, CEO, and other members of CET hosted a virtual investor update on Wednesday 23 June.
The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.
Annual Report 2020
We published our Annual Report 2020 on 09 March 2021. View the summary and download the full report or individual sections.
Sign up for announcements
Sign up to receive email notifications when we publish a stock exchange announcement.